Pathophysiological heterogeneity in Parkinson's disease: Neurophysiological insights from LRRK2 mutations

Mov Disord. 2017 Sep;32(9):1333-1335. doi: 10.1002/mds.27091. Epub 2017 Jul 7.

Authors

Maja Kojovic^{1

2}, Pangiotis Kassavetis¹, Isabel Pareés^{1

3}, Dejan Georgiev^{1

2}, Lorenzo Rocchi¹, Betina Balint^{1

4}, Tom Foltynie¹, John Rothwell¹, Kailash Bhatia¹

Affiliations

¹ Sobell Department of Motor Neuroscience and Movement Disorders, University College London, London, United Kingdom.
² Department of Neurology Ljubljana, University Medical Center Ljubljana, Slovenia.
³ Department of Neurology, Hospital Ruber Internacional, Madrid, Spain.
⁴ Department of Neurology, University Hospital, Heidelberg, Germany.

PMID: 28686318
DOI: 10.1002/mds.27091

No abstract available

Publication types

Letter

MeSH terms

Electromyography
Evoked Potentials, Motor / genetics*
Female
Humans
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / genetics*
Male
Middle Aged
Mutation / genetics*
Parkinson Disease / genetics*
Parkinson Disease / physiopathology*
Time Factors
Transcranial Magnetic Stimulation

Substances

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2